companydata.dkLoma Therapeutics ApS: Financial statements 2025
CVR: 44226189
Loma Therapeutics ApS (CVR 44226189) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -483,088 and a net result of DKK -3,540,377. Equity amounted to DKK -8,121,947. The company had 5 employees in the financial year.
- Gross Profit
- -483,088 kr.
- Profit/Loss
- -3,540,377 kr.
- Equity
- -8,121,947 kr.
- Total Assets
- 7,337,718 kr.
- Employees
- 5
Find more companies like Loma Therapeutics ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
Loma Therapeutics ApS has published its interim report for the period August 9, 2023 – December 31, 2024.
As of January 13, 2025, Alejandra Maria Cristina Bonifacini Mørk has joined the board of directors of Loma Therapeutics ApS.
As of January 13, 2025, Leif Helth Jensen has joined the board of directors of Loma Therapeutics ApS.
As of January 13, 2025, Stuart John Myles Collinson has joined the board of directors of Loma Therapeutics ApS.
As of January 13, 2025, Ralf Wagner has joined the board of directors of Loma Therapeutics ApS.
As of January 13, 2025, Northgaard Holding ApS is registered as an owner of Loma Therapeutics ApS with an ownership share of 5%.
About Loma Therapeutics ApS
Loma Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ditte Rahbæk Boilesen and Stephanie Holstein-Rønsbo. The company is owned by Northgaard Holding ApS, Ditte Boilesen Holding ApS and Holstein-Rønsbo Holding ApS. In 2025, the company reported a gross profit of DKK -483,088 and a net result of DKK -3,540,377. Equity amounted to DKK -8,121,947.